TY - JOUR
T1 - Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030
AU - Martelletti, Paolo
AU - Leonardi, Matilde
AU - Ashina, Messoud
AU - Burstein, Rami
AU - Cho, Soo Jin
AU - Charway-Felli, Augustina
AU - Dodick, David W.
AU - Gil-Gouveia, Raquel
AU - Grazzi, Licia
AU - Lampl, Christian
AU - MaassenVanDenBrink, Antoinette
AU - Minen, Mia T.
AU - Mitsikostas, Dimos Dimitrios
AU - Olesen, Jes
AU - Owolabi, Mayowa Ojo
AU - Reuter, Uwe
AU - Ruiz de la Torre, Elena
AU - Sacco, Simona
AU - Schwedt, Todd J.
AU - Serafini, Gianluca
AU - Surya, Nirmal
AU - Tassorelli, Cristina
AU - Wang, Shuu Jiun
AU - Wang, Yonggang
AU - Wijeratne, Tissa
AU - Raggi, Alberto
N1 - Publisher Copyright:
© 2023, Springer-Verlag Italia S.r.l., part of Springer Nature.
PY - 2023/12
Y1 - 2023/12
N2 - The 2030 Agenda for Sustainable Development sets out, through 17 Sustainable Development Goals (SDGs), a path for the prosperity of people and the planet. SDG 3 in particular aims to ensure healthy lives and promote well-being for all at all ages and includes several targets to enhance health. This review presents a “headache-tailored” perspective on how to achieve SDG 3 by focusing on six specific actions: targeting chronic headaches; reducing the overuse of acute pain-relieving medications; promoting the education of healthcare professionals; granting access to medication in low- and middle-income countries (LMIC); implementing training and educational opportunities for healthcare professionals in low and middle income countries; building a global alliance against headache disorders. Addressing the burden of headache disorders directly impacts on populations’ health, as well as on the possibility to improve the productivity of people aged below 50, women in particular. Our analysis pointed out several elements, and included: moving forward from frequency-based parameters to define headache severity; recognizing and managing comorbid diseases and risk factors; implementing a disease management multi-modal management model that incorporates pharmacological and non-pharmacological treatments; early recognizing and managing the overuse of acute pain-relieving medications; promoting undergraduate, postgraduate, and continuing medical education of healthcare professionals with specific training on headache; and promoting a culture that favors the recognition of headaches as diseases with a neurobiological basis, where this is not yet recognized. Making headache care more sustainable is an achievable objective, which will require multi-stakeholder collaborations across all sectors of society, both health-related and not health-related. Robust investments will be needed; however, considering the high prevalence of headache disorders and the associated disability, these investments will surely improve multiple health outcomes and lift development and well-being globally.
AB - The 2030 Agenda for Sustainable Development sets out, through 17 Sustainable Development Goals (SDGs), a path for the prosperity of people and the planet. SDG 3 in particular aims to ensure healthy lives and promote well-being for all at all ages and includes several targets to enhance health. This review presents a “headache-tailored” perspective on how to achieve SDG 3 by focusing on six specific actions: targeting chronic headaches; reducing the overuse of acute pain-relieving medications; promoting the education of healthcare professionals; granting access to medication in low- and middle-income countries (LMIC); implementing training and educational opportunities for healthcare professionals in low and middle income countries; building a global alliance against headache disorders. Addressing the burden of headache disorders directly impacts on populations’ health, as well as on the possibility to improve the productivity of people aged below 50, women in particular. Our analysis pointed out several elements, and included: moving forward from frequency-based parameters to define headache severity; recognizing and managing comorbid diseases and risk factors; implementing a disease management multi-modal management model that incorporates pharmacological and non-pharmacological treatments; early recognizing and managing the overuse of acute pain-relieving medications; promoting undergraduate, postgraduate, and continuing medical education of healthcare professionals with specific training on headache; and promoting a culture that favors the recognition of headaches as diseases with a neurobiological basis, where this is not yet recognized. Making headache care more sustainable is an achievable objective, which will require multi-stakeholder collaborations across all sectors of society, both health-related and not health-related. Robust investments will be needed; however, considering the high prevalence of headache disorders and the associated disability, these investments will surely improve multiple health outcomes and lift development and well-being globally.
KW - Global burden of disease study
KW - Low- and middle-income countries
KW - Medication overuse headache
KW - Migraine
KW - Sustainable development goals
KW - Tension-type headache
UR - http://www.scopus.com/inward/record.url?scp=85175021491&partnerID=8YFLogxK
U2 - 10.1186/s10194-023-01666-2
DO - 10.1186/s10194-023-01666-2
M3 - Review article
C2 - 37884869
AN - SCOPUS:85175021491
SN - 1129-2369
VL - 24
JO - Journal of Headache and Pain
JF - Journal of Headache and Pain
IS - 1
M1 - 140
ER -
